<?xml version="1.0" encoding="UTF-8"?>
<abstract id="abs0010">
 <p>Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.</p>
</abstract>
